2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$12.58-$0.17 (-1.34%)
Price as of Jul 14, 2026 5:46 AM EDT- $659.1MMarket Cap
- 46.55%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$12.58-$0.17 (-1.34%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK INC. | 16.65% | 8.6M | +1.0M (+11.73%) | Jun 30, 2024 |
BLACKROCK, INC. | 11.19% | 5.8M | +25,997 (+0.45%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 10.57% | 5.5M | -3.4M (-61.81%) | Dec 31, 2024 |
REDMILE GROUP, LLC | 8.45% | 4.4M | 0 (0.00%) | Mar 31, 2026 |
JPMORGAN CHASE & CO | 6.74% | 3.5M | -69,702 (-2.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 6.53% | 3.4M | +36,042 (+1.07%) | Dec 31, 2025 |
STATE STREET CORP | 5.28% | 2.7M | +444,749 (+16.28%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.79% | 2.0M | +18,654 (+0.95%) | Mar 31, 2026 |
SPDR SERIES TRUST | 3.15% | 1.6M | 0 (0.00%) | Apr 30, 2026 |
JPMORGAN TRUST II | 2.91% | 1.5M | -85,656 (-5.70%) | Mar 31, 2026 |
TIAA-CREF FUNDS | 1.39% | 716,025 | +160,972 (+22.48%) | Apr 30, 2026 |
JPMorgan Trust I | 1.06% | 547,374 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.92% | 474,923 | +416,482 (+87.69%) | Apr 30, 2026 |
VANGUARD HORIZON FUNDS | 0.73% | 377,777 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions719.7M (79.20%)
- Mutual Funds184.6M (20.32%)
- Insiders4.4M (0.48%)
- Other0 (0.00%)
Insider Transactions
- 0.48% (4.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 2Number of InsiderSelling (last 12 months)
- $16.9MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
PAKOLA STEVE Chief Medical Officer | Exempt | Jul 02, 2026 | $0.00 | 2,161 | $0.00 | 64,812 |
PAKOLA STEVE Chief Medical Officer | Exempt | Jul 02, 2026 | $16,985.46 | 2,161 | $7.86 | 215,170 |
PAKOLA STEVE Chief Medical Officer | Sell | Jul 02, 2026 | $29,476.04 | 2,161 | $13.64 | 213,009 |
PAKOLA STEVE Chief Medical Officer | Exempt | Jul 01, 2026 | $0.00 | 36,725 | $0.00 | 66,973 |
PAKOLA STEVE Chief Medical Officer | Exempt | Jul 01, 2026 | $288,658.50 | 36,725 | $7.86 | 249,734 |
PAKOLA STEVE Chief Medical Officer | Sell | Jul 01, 2026 | $472,283.50 | 36,725 | $12.86 | 213,009 |
PAKOLA STEVE Chief Medical Officer | Sell | Jun 29, 2026 | $216,472.32 | 19,608 | $11.04 | 213,009 |
PAKOLA STEVE Chief Medical Officer | Sell | Mar 10, 2026 | $53,033.40 | 5,124 | $10.35 | 247,926 |
PAKOLA STEVE Chief Medical Officer | In Kind | Feb 01, 2026 | $58,779.72 | 5,267 | $11.16 | 253,050 |
Mills Kenneth T. | Exempt | Jan 27, 2026 | $0.00 | 225,000 | $0.00 | 225,000 |
Mills Kenneth T. | Exempt | Jan 27, 2026 | $2.9M | 225,000 | $13.09 | 707,871 |
Mills Kenneth T. | In Kind | Jan 27, 2026 | $3.0M | 221,753 | $13.41 | 486,118 |
Simpson Curran Chief Executive Officer | Award | Jan 06, 2026 | $0.00 | 233,651 | $0.00 | 233,651 |
Christmas Patrick J. Chief Strategy & Legal Officer | Award | Jan 06, 2026 | $0.00 | 39,650 | $0.00 | 39,650 |
Simpson Curran Chief Executive Officer | Award | Jan 06, 2026 | $0.00 | 144,864 | $0.00 | 342,467 |
Chan Mitchell Chief Financial Officer | Award | Jan 06, 2026 | $0.00 | 39,650 | $0.00 | 39,650 |
Christmas Patrick J. Chief Strategy & Legal Officer | Award | Jan 06, 2026 | $0.00 | 73,749 | $0.00 | 215,367 |
Malzahn Craig Chief Technology Officer | Award | Jan 06, 2026 | $0.00 | 35,402 | $0.00 | 35,402 |
PAKOLA STEVE Chief Medical Officer | Award | Jan 06, 2026 | $0.00 | 35,402 | $0.00 | 35,402 |
Chan Mitchell Chief Financial Officer | Award | Jan 06, 2026 | $0.00 | 73,749 | $0.00 | 127,717 |
PAKOLA STEVE Chief Medical Officer | Award | Jan 06, 2026 | $0.00 | 65,847 | $0.00 | 258,317 |
Malzahn Craig Chief Technology Officer | Award | Jan 06, 2026 | $0.00 | 65,847 | $0.00 | 82,194 |
PAKOLA STEVE Chief Medical Officer | In Kind | Jan 02, 2026 | $262,756.80 | 18,247 | $14.40 | 192,470 |
Simpson Curran Chief Executive Officer | In Kind | Jan 02, 2026 | $267,249.60 | 18,559 | $14.40 | 197,603 |
Malzahn Craig Chief Technology Officer | In Kind | Jan 02, 2026 | $17,827.20 | 1,238 | $14.40 | 16,347 |
Christmas Patrick J. Chief Strategy & Legal Officer | In Kind | Jan 02, 2026 | $141,019.20 | 9,793 | $14.40 | 141,618 |
Simpson Curran Chief Executive Officer | Sell | Oct 09, 2025 | $262,634.82 | 20,811 | $12.62 | 216,162 |
Simpson Curran Chief Executive Officer | Sell | Sep 29, 2025 | $76,468.72 | 7,624 | $10.03 | 236,973 |
Simpson Curran Chief Executive Officer | Sell | Sep 10, 2025 | $77,494.68 | 7,734 | $10.02 | 244,597 |
Malzahn Craig Chief Technology Officer | In Kind | Sep 01, 2025 | $2,089.62 | 234 | $8.93 | 17,585 |